These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32615719)

  • 1. Apolipoprotein B Levels Predict Future Development of Hypertension Independent of Visceral Adiposity and Insulin Sensitivity.
    Han SJ; Fujimoto WY; Kahn SE; Leonetti DL; Boyko EJ
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):351-358. PubMed ID: 32615719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance.
    Han SJ; Boyko EJ; Fujimoto WY; Kahn SE; Leonetti DL
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4626-4633. PubMed ID: 29029184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans.
    Hayashi T; Boyko EJ; McNeely MJ; Leonetti DL; Kahn SE; Fujimoto WY
    Diabetes; 2008 May; 57(5):1269-75. PubMed ID: 18299316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans.
    Hayashi T; Boyko EJ; Leonetti DL; McNeely MJ; Newell-Morris L; Kahn SE; Fujimoto WY
    Ann Intern Med; 2004 Jun; 140(12):992-1000. PubMed ID: 15197016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Intra-Abdominal Fat Predicts the Risk of Hypertension in Japanese Americans.
    Sullivan CA; Kahn SE; Fujimoto WY; Hayashi T; Leonetti DL; Boyko EJ
    Hypertension; 2015 Jul; 66(1):134-40. PubMed ID: 26063668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
    de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
    Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adiposity, not abdominal subcutaneous fat area, is associated with high blood pressure in Japanese men: the Ohtori study.
    Koh H; Hayashi T; Sato KK; Harita N; Maeda I; Nishizawa Y; Endo G; Fujimoto WY; Boyko EJ; Hikita Y
    Hypertens Res; 2011 May; 34(5):565-72. PubMed ID: 21228782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype.
    Hwang YC; Hayashi T; Fujimoto WY; Kahn SE; Leonetti DL; McNeely MJ; Boyko EJ
    Int J Obes (Lond); 2015 Sep; 39(9):1365-70. PubMed ID: 25920773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of C-reactive protein, adiponectin and leptin in the association between abdominal adiposity and insulin resistance in middle-aged individuals.
    Noordam R; Boersma V; Verkouter I; le Cessie S; Christen T; Lamb HJ; Rosendaal FR; Willems van Dijk K; van Heemst D; de Mutsert R
    Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1306-1314. PubMed ID: 32507340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
    Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
    Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in CT-measured abdominal subcutaneous and visceral but not thigh fat areas predict future insulin sensitivity.
    Liu AW; Song SO; Hayashi T; Sato KK; Kahn SE; Leonetti DL; Fujimoto WY; Boyko EJ
    Diabetes Res Clin Pract; 2019 Aug; 154():17-26. PubMed ID: 31228493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients.
    Taniguchi A; Nakai Y; Sakai M; Yoshii S; Hamanaka D; Hatae Y; Kawata M; Yamanouchi K; Okumura T; Doi K; Tokuyama K; Nagasaka S; Fukushima M
    Metabolism; 2002 May; 51(5):544-8. PubMed ID: 11979383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans.
    Hayashi T; Boyko EJ; Leonetti DL; McNeely MJ; Newell-Morris L; Kahn SE; Fujimoto WY
    Diabetes Care; 2003 Mar; 26(3):650-5. PubMed ID: 12610016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in visceral adiposity is an independent predictor of future arterial pulse pressure.
    Han SJ; Fujimoto WY; Kahn SE; Leonetti DL; Boyko EJ
    J Hypertens; 2018 Feb; 36(2):299-305. PubMed ID: 28857792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance.
    Ben Ali S; Belfki-Benali H; Ahmed DB; Haddad N; Jmal A; Abdennebi M; Romdhane HB
    Clin Exp Hypertens; 2016; 38(4):370-4. PubMed ID: 27149156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral adiposity and the prevalence of hypertension in Japanese Americans.
    Hayashi T; Boyko EJ; Leonetti DL; McNeely MJ; Newell-Morris L; Kahn SE; Fujimoto WY
    Circulation; 2003 Oct; 108(14):1718-23. PubMed ID: 12975250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study.
    Porter SA; Pedley A; Massaro JM; Vasan RS; Hoffmann U; Fox CS
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):139-46. PubMed ID: 23162012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
    Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X
    Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.
    Neeland IJ; Turer AT; Ayers CR; Powell-Wiley TM; Vega GL; Farzaneh-Far R; Grundy SM; Khera A; McGuire DK; de Lemos JA
    JAMA; 2012 Sep; 308(11):1150-9. PubMed ID: 22990274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.